Related Experiment Video
Updated: Jun 2, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Vaccination, consent and multidose vials
Mark R Diamond1, Angela O'Brien-Malone
1School of Psychology, University of Tasmania, Hobart, TAS. diamondm@utas.edu.au
Abstract:
Multidose vials (MDVs) for injectable therapeutic agents, including vaccines, pose a risk of infection to injected patients as a result of contamination of the vials. The Australian Government Department of Health and Ageing (DoHA) distributed the vaccine against pandemic (H1N1) 2009 influenza in MDVs. The distribution was accompanied by consent forms. The consent forms provided an inadequate basis for a discussion with patients about the risks associated with the use of MDVs. The High Court of Australia has previously held that medical practitioners who fail to explain the material risks of medical procedures to their patients might be held liable in negligence for any adverse sequelae of the procedures, even if the risks are very low. Medical practitioners, nurses, medical indemnity insurers and the DoHA should prepare now for the probable future use of MDVs by developing a consent form that would provide a solid foundation for a discussion of material risks with patients seeking vaccination.
Related Concept Videos
Vaccinations
Vaccine Production
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Vaccines
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

